[1]
T. A. Abdullah and A. B. Qader, “Comparison of dissolution release of commercially available extended release carbamazepine tablets in Iraqi drug market using in vitro USP II method”, ZJMS, vol. 20, no. 2, pp. 1288–1293, Aug. 2016.